First lady Jill Biden visits Mays Cancer Center
First lady Jill Biden toured Mays Cancer Center at UT Health San Antonio and praised its efforts in addressing disparities in cancer rates among Latinos.
First lady Jill Biden toured Mays Cancer Center at UT Health San Antonio and praised its efforts in addressing disparities in cancer rates among Latinos.
Contact: Steven Lee, 210-450-3823, lees22@uthscsa.edu SAN ANTONIO – First lady Jill Biden toured Mays Cancer Center at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), and praised its efforts in addressing disparities in cancer rates among Latinos. The visit came on the same day as the opening of the […]
The FDA has approved pacritinib for myelofibrosis patients with low platelet counts. Investigators at the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, played a lead role in gaining U.S. Food and Drug Administration approval of pacritinib to treat the chronic leukemia known as myelofibrosis. The FDA granted accelerated approval of the […]
An internationally recognized physician-scientist of Mays Cancer Center at UT Health San Antonio, together with SignalRx Pharmaceuticals Inc., have secured two National Cancer Institute business grants to further develop drugs on a pathway to first-in-human cancer clinical trials. The clinical translational researcher, Daruka Mahadevan, MD, PhD, division chief of hematology and medical oncology at UT […]
Structural racism, rather than disease, leads to inequities, authors write Contacts: Will Sansom, (210) 567-2579, sansom@uthscsa.edu Steven Lee, (210) 450-3823, lees22@uthscsa.edu SAN ANTONIO (March 28, 2022) — Black patients with cancer experienced significantly worse outcomes after COVID-19 diagnosis than non-Hispanic white cancer patients in a study published March 28 in JAMA Network Open. Investigators of […]
The UT Health San Antonio School of Dentistry has partnered with The Oral Cancer Foundation to host The San Antonio Oral Cancer Walk on Saturday, April 23, in observance of the 22nd Annual Oral Cancer Awareness Month.
Lindsay Fry is a breast cancer survivor who was first diagnosed in 2019. Her treatment regimen of surgery, radiation and chemotherapy began in fall 2019. Shortly after completing her treatment, Fry became the first participant in a new clinical trial at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) that aims to help breast cancer survivors regain their energy and remain cancer free.
What if a daily or weekly blood sample could monitor each patient’s risk of metastasis, indicating the need for aggressive therapy before cancer spread is established? That’s the ultimate goal of studies published by researchers from The University of Texas Health Science Center at San Antonio.
Brianna Garcia wondered why her heart raced when she exercised and why she was tired all the time. Her doctor in Laredo referred her to a team of specialists at UT Health San Antonio. Six weeks of care followed and experts unraveled the teen’s medical mystery.
An MRI scan called restriction spectrum imaging greatly improves the detection of prostate cancer progression, according to a published study by researchers at The University of Texas Health Science Center at San Antonio, also known as UT Health San Antonio.